RWA
EDIT icon

Ropes Wealth Advisors’s Editas Medicine EDIT Stock Holding History

Ropes Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,273
Closed -$89K – 399
2020
Q4 		$89K Buy
1,273
+1,033
+430% +$42.4K 0.01% 326
2020
Q3 		$7K Hold
240
– – ﹤0.01% 540
2020
Q2 		$7K Hold
240
– – ﹤0.01% 470
2020
Q1 		$5K Hold
240
– – ﹤0.01% 452
2019
Q4 		$7K Hold
240
– – ﹤0.01% 485
2019
Q3 		$5K Hold
240
– – ﹤0.01% 511
2019
Q2 		$6K Hold
240
– – ﹤0.01% 509
2019
Q1 		$6K Buy
+240
New +$5.43K ﹤0.01% 472

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ropes Wealth Advisors's EDIT Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 1,273 shares — an estimated $89K sold.

Ropes Wealth Advisors first reported a position in EDIT in Q1 2019 and held it in 8 quarters. The position peaked at $89K in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • Ropes Wealth Advisors reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • Ropes Wealth Advisors sold 1,273 Editas Medicine shares in Q1 2021, an estimated $89K.
  • Ropes Wealth Advisors first reported a position in Editas Medicine in Q1 2019 and held it in 8 quarters.
  • Ropes Wealth Advisors's Editas Medicine position peaked at $89K in Q4 2020.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.